Poly(adp-ribose) polymerase 1 deficiency attenuates amyloid pathology, neurodegeneration, and cognitive decline in a familial Alzheimer disease model
Data files
May 08, 2026 version files 108.48 MB
-
Figures.zip
108.45 MB
-
README.md
26.16 KB
Abstract
Poly(ADP-ribose) (PAR) polymerase-1 (PARP1) has been implicated in DNA damage responses and neuroinflammation in Alzheimer disease (AD), yet its role in amyloid-β (Aβ) pathology remains unclear. Here, we show that PARP1 activation drives Aβ pathology and neurodegeneration. Using a sensitive ELISA, we observed significantly elevated PAR levels in the cerebrospinal fluid (CSF) of patients with mild cognitive impairment (MCI) and AD compared to controls. In vitro, oligomeric Aβ 1-42 activated PARP1 and induced DNA damage, while genetic or pharmacological inhibition of PARP1 conferred neuroprotection. In vivo, PARP1 knockout in the 5XFAD mouse model of amyloidosis led to reduced amyloid plaque burden, preserved synaptic and neuronal integrity, attenuated glial activation and neuroinflammation, and rescued cognitive deficits. Mechanistically, PARP1 deficiency decreased amyloid precursor protein (APP) and BACE1 levels, altered γ-secretase complex composition, and enhanced Aβ degradation via neprilysin. These findings position PARP1 as a critical mediator of Aβ toxicity and neurodegeneration, suggesting its inhibition as a promising therapeutic strategy for AD.
Dataset overview
This dataset contains the underlying data files associated with the figures in the manuscript. The main data package is organized inside Figures.zip which unzips to theFigures folder. Within this folder, each subfolder corresponds to one main figure or a grouped set of related main and supplementary figures.
The dataset includes raw image files, GraphPad Prism analysis files, SPSS files, MATLAB code, behavioral analysis files, raw CSV files, and supporting image-analysis outputs. Raw CSV files are included wherever applicable to provide the numerical values used for graph generation and statistical analysis in an open, unformatted, and reusable format.
General file organization
The primary folder is:
Figures/
Within Figures/, the data are organized by figure:
Figure 1/
Figure 2/
Figure 3, S2, S3/
Figure 4/
Figure 5/
Figure 6, S4/
Figure 7, S5/
Figure 8/
Each figure folder contains some or all of the following file types:
- Raw image files, including
.png,.tif, and raw immunoblot or immunostaining source images. - GraphPad Prism files, where statistical analyses and graph generation were performed.
- Raw CSV files containing the numerical values used for graphs and statistical analyses.
- SPSS files for correlation analyses, where applicable.
- MATLAB code for image analysis, where applicable.
- Adobe Illustrator or Photoshop files when these files were used for figure assembly or merged image visualization.
General analysis notes
GraphPad Prism was used for graph generation and statistical analysis unless otherwise specified. For grouped comparisons, values were organized by experimental or diagnostic group in Prism and analyzed using the statistical test indicated in the corresponding Prism file.
Raw CSV files are provided in addition to Prism, SPSS, or other software-specific files so that the data can be accessed without proprietary software.
Immunoblot densitometry was quantified using Fiji. Raw immunoblot images were opened in Fiji, bands corresponding to each protein of interest were selected, and densitometry values were measured. The resulting values were exported and used for graph generation and statistical analysis in GraphPad Prism.
For RT-PCR analyses, GAPDH was used as the normalization control. For each sample, delta Ct was calculated as:
delta Ct = target gene Ct - GAPDH Ct
Delta delta Ct was calculated by comparing each sample or group to the appropriate control group:
delta delta Ct = delta Ct of sample - mean delta Ct of control group
Fold change was calculated using:
fold change = 2^(-delta delta Ct)
For all RT-PCR-related CSV files in this dataset, the reported fold change values correspond to 2^(-delta delta Ct) values.
Human CSF sample and de-identification note
All human CSF samples were received as de-identified specimens from Cleveland Clinic and Johns Hopkins Medicine. No direct participant identifiers are included in these files. The datasets include only limited, non-identifiable information required for analysis, including diagnostic group and clinically reported CSF biomarker values where available.
Figure 1 data files
Overview
The Figure 1 folder contains the underlying numerical data and analysis files used to generate Figure 1A, 1B, 1C, 1D, 1E, and 1F. The GraphPad Prism analyses for grouped comparisons are included in:
Figure 1/Figure 1.prism
Raw CSV files containing the numerical values used for these analyses are included in:
Figure 1/Raw CSV files
These CSV files provide the underlying tabular data used to generate the corresponding Prism and SPSS analyses and are included to support accessibility, reuse, and downstream analysis.
Figure 1A and Figure 1D: PAR ELISA data
The Prism file Figure 1.prism contains PAR ELISA values measured in CSF samples. Samples were received as de-identified specimens from Cleveland Clinic and Johns Hopkins Medicine.
Data were organized in Prism by diagnostic group. PAR ELISA values were pasted into separate groups corresponding to Control, MCI, and AD. Group comparisons were performed using one-way ANOVA.
Data organization in Prism:
Control: PAR ELISA values from samples classified as Control.
MCI: PAR ELISA values from samples classified as MCI.
AD: PAR ELISA values from samples classified as AD.
Figure panels supported by this file:
Figure 1A: PAR ELISA values from the Johns Hopkins Medicine cohort, grouped by diagnostic category.
Figure 1D: PAR ELISA values from the Cleveland Clinic cohort, grouped by diagnostic category.
Figure 1B and Figure 1E: CSF Aβ42/Aβ40 ratio data
The Prism file Figure 1.prism contains the clinically reported CSF Aβ42/Aβ40 ratio values. These values were obtained from de-identified clinical information provided by Cleveland Clinic and Johns Hopkins Medicine.
Data were organized in Prism by diagnostic group. Aβ42/Aβ40 ratio values were pasted into separate groups corresponding to Control, MCI, and AD. Group comparisons were performed using one-way ANOVA.
Data organization in Prism:
Control: Aβ42/Aβ40 ratio values from samples classified as Control.
MCI: Aβ42/Aβ40 ratio values from samples classified as MCI.
AD: Aβ42/Aβ40 ratio values from samples classified as AD.
Figure panels supported by this file:
Figure 1B: CSF Aβ42/Aβ40 ratio values from the Johns Hopkins Medicine cohort, grouped by diagnostic category.
Figure 1E: CSF Aβ42/Aβ40 ratio values from the Cleveland Clinic cohort, grouped by diagnostic category.
Figure 1C and Figure 1F: SPSS correlation analysis files
Figure 1C and Figure 1F were analyzed using SPSS. Separate SPSS files are provided for the Johns Hopkins Medicine and Cleveland Clinic datasets. For each analysis, files are provided in .sav and .spv formats. The .sav files contain the SPSS dataset, and the .spv files contain the corresponding SPSS output and graph.
SPSS files are labeled using the following format:
1C_[name of the analysis]_[source institution]
1F_[name of the analysis]_[source institution]
Data were entered into SPSS in tabular format. Each row represents one de-identified sample. The values used for the correlation analysis were pasted into SPSS along with the corresponding diagnostic group assignment.
Diagnostic group coding:
1 = Control
2 = MCI
3 = AD
Correlation analyses were performed in SPSS using the pasted values for each source institution. The analysis was used to assess the relationship between PAR ELISA values and clinically reported CSF Aβ42/Aβ40 ratio values.
Scatter plots were generated in SPSS. Each dot represents one de-identified sample. Dot colors were assigned according to the diagnostic group code.
Figure panels supported by these files:
Figure 1C: Correlation analysis for the Johns Hopkins Medicine cohort.
Figure 1F: Correlation analysis for the Cleveland Clinic cohort.
Figure 2 and Supplementary Figure S1 data files
Overview
Figure 2 and Supplementary Figure S1 are related and are organized together in the Figure 2 folder. This folder contains raw image files, raw numerical data files, and the GraphPad Prism analysis file used to generate Figure 2 and Supplementary Figure S1.
The Prism file is named:
Figure 2/Figure 2, S1.prism
Raw CSV files containing numerical values used for the graphs are included in:
Figure 2/Raw CSV files
Raw western blot images
Raw western blot images are organized into subfolders corresponding to the relevant figure panel number. Folder names follow the figure panel format:
2[letter]
S1[letter]
The raw western blot image folders include:
2A
S1A
S1B
S1E
Each folder contains the raw western blot image files used for the corresponding figure panel.
Except this folder
S1I- Compiled western blot image in png format- as it was developed using an x-ray film
Raw immunostaining images
Raw immunostaining images are organized into subfolders corresponding to the relevant figure panel number. These folders contain the raw image files used for the immunostaining panels in Figure 2 and Supplementary Figure S1.
The raw immunostaining image folders include:
2D
S1G
Raw CSV files
Raw CSV files contain the numerical data used to generate each graph in Figure 2 and Supplementary Figure S1. CSV files are labeled according to the corresponding figure panel number using the format:
2[letter]
S1[letter]
When densitometry data from the same western blot image are used to generate more than one graph, the related quantification files are grouped together. For example, if quantification for PAR and γH2AX comes from the same Figure 2A western blot image, the densitometry data used for Figure 2B and Figure 2C are organized together as:
2B, 2C
This organization indicates that the related graph data were derived from the same western blot source image but were quantified as separate outcome measures.
Figure 3, Supplementary Figure S2, and Supplementary Figure S3 data files
Overview
Figure 3, Supplementary Figure S2, and Supplementary Figure S3 are organized together because the experiments and analyses are related. The folder Figure 3, S2, S3 contains raw image files, raw numerical data files, and the Prism analysis file used to generate these figure panels.
The Prism file is named:
Figure 3, S2, S3/Figure 3, S2, S3.prism
Raw CSV files are included in:
Figure 3, S2, S3/Raw CSV files
Supplementary Figure S2A: Breeding scheme
The breeding scheme image is included in:
Figure 3, S2, S3/S2A
This file shows the breeding strategy used to generate the experimental mouse genotypes used for the Figure 3-related analyses.
Supplementary Figure S2B: Agarose gel genotyping image
The raw agarose gel genotyping image is included as a .tif file in:
Figure 3, S2, S3/S2B
This folder contains the source genotyping image used to identify the mouse genotypes included in the study. The genotypes represented include:
WT
5xFAD
PARP1 knockout
5xFAD-PARP1 knockout
Supplementary Figure S2C: Immunoblot genotype validation
The raw immunoblot image showing genotype validation is included in:
Figure 3, S2, S3/S2C
This immunoblot shows protein-level validation of the genotype groups used in the study. The genotypes represented include:
WT
5xFAD
PARP1 knockout
5xFAD-PARP1 knockout
Supplementary Figure S2D: RT-PCR data
Raw RT-PCR data for Supplementary Figure S2D are included in the corresponding CSV files in:
Figure 3, S2, S3/Raw CSV files
These data were used to assess genotype-related transcript levels. The RT-PCR values used for analysis are also included in:
Figure 3, S2, S3/Figure 3, S2, S3.prism
The values reported in the RT-PCR CSV files are 2^(-delta delta Ct) fold change values.
Figure 3A: ThioS plaque immunostaining images
Raw ThioS plaque immunostaining images are included in:
Figure 3, S2, S3/3A
This folder contains the raw immunostaining image files used for Figure 3A.
Figure 3B: ThioS plaque quantification
The numerical quantification data corresponding to Figure 3A are provided as CSV files labeled 3B in:
Figure 3, S2, S3/Raw CSV files
The 3B CSV files contain raw numerical values used to quantify ThioS-positive plaque burden or related plaque measurements shown in Figure 3B. These values are also included in Figure 3, S2, S3.prism.
Figure 3C: Aβ40 serial extraction data
The CSV files for Figure 3C contain Aβ40 measurements from serially extracted brain fractions. The extraction fractions include:
TBS
TBSX
70% formic acid
These files contain raw numerical values used to compare Aβ40 levels across the relevant genotype groups and extraction fractions. The same values are included in Figure 3, S2, S3.prism.
Figure 3D: Aβ42 serial extraction data
The CSV files for Figure 3D contain Aβ42 measurements from serially extracted brain fractions. The extraction fractions include:
TBS
TBSX
70% formic acid
These files contain raw numerical values used to compare Aβ42 levels across the relevant genotype groups and extraction fractions. The same values are included in Figure 3, S2, S3.prism.
Supplementary Figure S3A: Immunoblot source files
The immunoblot source files for Supplementary Figure S3A are included in:
Figure 3, S2, S3/S3A
This folder contains the raw immunoblot image files used for Supplementary Figure S3A.
Supplementary Figure S3B and Supplementary Figure S3C: Immunoblot quantification
The quantification data for Supplementary Figure S3B and Supplementary Figure S3C are included in:
Figure 3, S2, S3/Figure 3, S2, S3.prism
The same numerical values are also provided as CSV files labeled S3B, S3C in:
Figure 3, S2, S3/Raw CSV files
Figure 4 data files
Overview
The Figure 4 folder contains raw immunostaining image files, raw numerical data files, MATLAB code, and the Prism analysis file used to generate the Figure 4 panels. Raw image files are organized into figure panel-specific folders. Raw CSV files containing numerical values used for the graphs are included in:
Figure 4/Raw CSV Files
Raw immunostaining images
Raw immunostaining image files are provided as .png and/or .tif files in their respective figure panel folders.
The raw immunostaining image folders include:
4A
4C
4E
4G
Raw CSV files
Raw CSV files are labeled according to the corresponding figure panel number and contain raw numerical data used for graph generation and statistical analysis.
The raw CSV files include data for:
4B
4D
4E
4F
4H
Figure 4B: PSD95 density around Aβ plaques
Figure 4B contains PSD95 density measurements around Aβ plaques generated from the raw immunostaining images shown in Figure 4A. These data were quantified using the MATLAB script:
MATLAB CODE FOR 4B.m
The MATLAB script identifies Aβ-positive plaque regions, expands the plaque boundary, masks the Aβ signal from the PSD95 channel, and calculates PSD95-positive area or density within the defined peri-plaque region.
The input images were paired using image file name flags for Aβ and PSD95 channels. The script prompts the user to select the input image directory, output directory, Aβ image flag, and PSD95 image flag. The output includes quantified PSD95 measurements and processed mask images generated during the analysis.
The MATLAB analysis pipeline for Figure 4B was as follows:
- Raw Aβ and PSD95 immunostaining images were placed in the same input folder.
- Aβ and PSD95 images were identified using user-defined filename flags.
- The PSD95 signal was extracted from the appropriate image channel.
- Aβ-positive plaque regions were thresholded using an automated thresholding approach.
- The Aβ plaque mask was dilated to define the peri-plaque region.
- The Aβ signal was excluded from the PSD95 channel to measure PSD95 signal surrounding, rather than within, the plaque.
- PSD95-positive area or density was calculated within the defined peri-plaque region.
- Quantified values were exported as
4B.csvfor graph generation and statistical analysis.
The raw numerical values for Figure 4B are provided in:
Figure 4/Raw CSV Files
Figure 4D and Figure 4H: Percent area quantification
Figure 4D and Figure 4H contain percent area quantification data generated from the corresponding raw immunostaining images. Percent area was quantified using an ImageJ-based analysis pipeline.
The ImageJ analysis pipeline for percent area quantification was as follows:
- Raw immunostaining images were opened in ImageJ.
- Images were converted to the appropriate grayscale or single-channel format for analysis.
- A consistent threshold was applied across images within each analysis to identify positive immunostaining signal.
- The threshold-positive area was measured within the defined ROI.
- Percent area was calculated as:
percent area = threshold-positive area / total ROI area × 100
- The resulting values were exported and used for graph generation and statistical analysis.
The raw percent area values for Figure 4D and Figure 4H are provided in:
Figure 4/Raw CSV Files
Figure 4E: Quantification data
Raw numerical values used to generate Figure 4E are provided as CSV files in:
Figure 4/Raw CSV Files
These files contain the quantification values used for graph generation and statistical analysis in Prism.
Figure 4F: Cell count data
Figure 4F contains cell count data generated using Stereo Investigator software. Counts were performed using the Optical Fractionator workflow.
The counting output included the estimated population using the user-defined section thickness and the total number of markers counted. These values were exported and used for graph generation and statistical analysis.
Stereo Investigator output fields included:
Estimated population using user-defined section thickness: Estimated total population calculated by the Optical Fractionator workflow.
Total markers counted: Total number of counted markers used to generate the population estimate.
The raw numerical values for Figure 4F are provided in:
Figure 4/Raw CSV Files
Figure 5 data files
Overview
The Figure 5 folder contains raw immunostaining image files, raw numerical data files, and the Prism analysis file used to generate the Figure 5 panels. Raw image files are organized into figure panel-specific folders and genotype-specific subfolders. Raw CSV files containing numerical values used for the graphs are included in:
Figure 5/Raw CSV Files
The Prism file is named:
Figure 5/Figure 5.prism
Figure 5A: GFAP and IBA1 immunostaining images
Raw immunostaining images for Figure 5A are organized into two main subfolders:
Figure 5/5A/GFAP
Figure 5/5A/IBA1
The GFAP image folder contains four genotype-specific subfolders:
WT
PARP1ko
FAD
FADPARP1KO
Each genotype-specific folder contains the corresponding GFAP, DAPI, and Aβ channel images as .png files. Each folder also includes a Photoshop MERGED .psd file containing the merged image used for visualization.
The IBA1 image folder contains four genotype-specific subfolders:
WT
PARP1ko
FAD
FADPARP1KO
Each genotype-specific folder contains the corresponding IBA1, DAPI, and Aβ channel images as .png files. Each folder also includes a Photoshop MERGED .psd file containing the merged image used for visualization.
Figure 5B and Figure 5C: GFAP and IBA1 percent area quantification
Raw CSV files containing the numerical values used for Figure 5B and Figure 5C are included in:
Figure 5/Raw CSV Files
The CSV files are labeled according to the corresponding figure panel:
5B: GFAP percent area quantification
5C: IBA1 percent area quantification
The percent area values were generated from the corresponding raw immunostaining images using a Fiji-based image analysis pipeline.
The Fiji analysis pipeline for percent area quantification was as follows:
- Raw immunostaining images were opened in Fiji.
- The relevant channel was selected for analysis.
- Images were converted to the appropriate grayscale or single-channel format.
- A consistent threshold was applied across images within each analysis to identify positive GFAP or IBA1 immunostaining signal.
- The threshold-positive area was measured within the defined ROI.
- Percent area was calculated as:
percent area = threshold-positive area / total ROI area × 100
- The resulting percent area values were exported as CSV files and used for graph generation and statistical analysis in Prism.
Figures 5D-5H: RT-PCR fold change data
Figures 5D, 5E, 5F, 5G, and 5H contain RT-PCR data analyzed as fold change values. Numerical values for these panels are included in:
Figure 5/Raw CSV Files
Figure 5/Figure 5.prism
The values reported in the RT-PCR CSV files are 2^(-delta delta Ct) fold change values.
Figure 6 and Supplementary Figure S4 data files
Overview
Figure 6 and Supplementary Figure S4 contain behavioral testing data and are organized together because the panels are related. The Figure 6, S4 folder contains behavior track plots, raw numerical data files, and the Prism analysis file used to generate the behavior graphs.
Raw CSV files are included in:
Figure 6, S4/Raw CSV Files
Behavior track plots
Behavior track plots for the Morris water maze and Y-maze were copied directly from ANY-maze software into an Adobe Illustrator file. Open field track plots were copied directly from PAS software into an Adobe Illustrator file. Because these track plots were copied directly from the behavior software into Illustrator, no separate source image version is available.
Morris water maze data
The Morris water maze data are included in CSV files labeled:
6B, S4A, S4B (Morris water maze)
These files contain raw behavioral measurements used for the Morris water maze analyses.
Figure panels supported by these files:
Figure 6B: Escape latency.
Supplementary Figure S4A: Distance traveled in the target quadrant.
Supplementary Figure S4B: Platform entries.
Y-maze data
The Y-maze data are included in CSV files labeled:
6E, 6F (Y-maze)
Figure panels supported by these files:
Figure 6E: Arm entries.
Figure 6F: Percent alternation.
Open field data
The open field data are included in CSV files labeled:
S4D, S4E (Open field)
Figure panels supported by these files:
Supplementary Figure S4D: Percent time or activity in the periphery.
Supplementary Figure S4E: Distance traveled.
Figure 7 and Supplementary Figure S5 data files
Overview
Figure 7 and Supplementary Figure S5 are organized together because the analyses are related. The folder Figure 7, S5 contains raw immunoblot image files, raw numerical data files, and the Prism analysis file used to generate Figure 7 and Supplementary Figure S5.
The Prism file is named:
Figure 7, S5/Figure 7, S5.prism
Raw CSV files are included in:
Figure 7, S5/Raw CSV Files
Figure 7A: hAPP ELISA data
The CSV file labeled 7A contains the hAPP ELISA values used to generate Figure 7A. These values are also included in:
Figure 7, S5/Figure 7, S5.prism
Figure 7B: Immunoblot source image
The raw immunoblot image used for Figure 7B is included in:
Figure 7, S5/7B
This folder contains the immunoblot source file used for the densitometry analyses shown in Figure 7C-7L and Supplementary Figure S5A-S5B.
Figure 7C-7L and Supplementary Figure S5A-S5B: Immunoblot densitometry data
The CSV files labeled 7C-7L, S5A, S5B contain densitometry values quantified from the Figure 7B immunoblot. These values are also included in:
Figure 7, S5/Figure 7, S5.prism
The graphs generated from the Figure 7B immunoblot densitometry are organized in the following order:
Figure 7C: FL-APP
Figure 7D: APP-CTFα + APP-CTFβ
Figure 7E: APP-CTFα
Figure 7F: APP-CTFβ
Figure 7G: sAPPα
Figure 7H: sAPPβ
Figure 7I: BACE1
Figure 7J: PSEN1
Figure 7K: Nicastrin
Figure 7L: NEP2/neprilysin
Supplementary Figure S5A: PSEN2
Supplementary Figure S5B: IDE
Supplementary Figure S5A and Supplementary Figure S5B were included in the supplementary figures due to space limitations in the main figure.
Figure 8 data files
Overview
The Figure 8 folder contains the Prism analysis file and raw numerical data file used to generate Figure 8.
The Prism file is named:
Figure 8/Figure 8.prism
The folder contains one raw CSV file with the fold change values used for Figure 8. This file contains the numerical data used for graph generation and statistical analysis in Prism.
Data organization
The fold change values were organized in Prism according to the corresponding experimental groups shown in Figure 8. The same numerical values are provided in the CSV file to support accessibility, reuse, and downstream analysis.
The data in the Figure 8 CSV file are organized in the following order:
BACE1
PSEN1
PSEN2
Nicastrin
IDE
NEP2/neprilysin
Abbreviations
AD: Alzheimer’s disease
ANOVA: Analysis of variance
APP: Amyloid precursor protein
APP-CTF: APP C-terminal fragment
Aβ: Amyloid-beta
BACE1: Beta-secretase 1
CSV: Comma-separated values
CSF: Cerebrospinal fluid
Ct: Cycle threshold
DAPI: 4′,6-diamidino-2-phenylindole
ELISA: Enzyme-linked immunosorbent assay
FAD: 5xFAD
Fiji: Fiji image analysis software
FL-APP: Full-length APP
GAPDH: Glyceraldehyde 3-phosphate dehydrogenase
GFAP: Glial fibrillary acidic protein
hAPP: Human amyloid precursor protein
IBA1: Ionized calcium-binding adapter molecule 1
IDE: Insulin-degrading enzyme
ImageJ: ImageJ image analysis software
MATLAB: Matrix Laboratory
MCI: Mild cognitive impairment
MWM: Morris water maze
NEP2: Neprilysin 2
PAR: Poly(ADP-ribose)
PARP1: Poly(ADP-ribose) polymerase 1
PARP1ko: PARP1 knockout
PAS: Open field behavior analysis software used for this study
PSD: Photoshop document
PSD95: Postsynaptic density protein 95
PSEN1: Presenilin 1
PSEN2: Presenilin 2
ROI: Region of interest
RT-PCR: Reverse transcription polymerase chain reaction
SPSS: IBM SPSS Statistics
TBS: Tris-buffered saline
TBSX: Tris-buffered saline with detergent
ThioS: Thioflavin S
WT: Wild-type
γH2AX: Gamma H2A histone family member X
Animal
5XTg FAD (MMRRC Strain #034840-JAX) mice was obtained from the Jackson Laboratories (Bar Harbor, ME). The lab-maintained PARP1 -/- mice line was used to cross 5XTg FAD and PARP1-/- together. After two generations, the desired littermates were aged and used for further experimentation. NIH Guide for the Care and Use of Experimental Animals and Johns Hopkins University Animal Care and Use Committee were followed for all housing, breeding, and subsequent procedures.
Antibodies
Primary antibodies used for Western blotting and immunochemistry are listed below. These included antibodies against APP, APP-CTF, sAPPβ, Nicastrin, BACE1, PSEN1, PSEN2, NEP2, IDE, β-Actin, IBA1, GFAP, Aβ (6E10 and 4G8), NeuN, RTN3, PSD95, PARP1, PAR, and γH2AX. All antibodies were obtained from commercial sources as detailed, except for the poly-ADP-ribose (PAR) antibody, which was prepared in-house. All commercial antibodies are listed in Table 3 along with their source details.
Human CSF samples and PAR ELISA
Participants in the Johns Hopkins University BIOCARD study (33) and at the Cleveland Clinic underwent annual evaluations, including detailed medical history, physical examination, and neuropsychological testing. CSF specimens were processed within one hour of collection: samples were centrifuged, divided into aliquots, and stored at –80 °C at either the Cleveland Clinic Lou Ruvo Center for Brain Health Biobank or the Johns Hopkins University repository. For PAR quantification, two monoclonal anti-PAR antibodies (clones #19 and #25) were employed in an ELISA format. Ninety-six–well plates (NUNC, Cat. #46051) were coated overnight at 4 °C with clone #19 (5 µg/mL) as the capture antibody. Purified PAR standards (0–200 nM) and CSF samples from control or PD subjects were added and incubated for 1 hour at room temperature. Wells were washed five times with PBST (0.05% Tween-20 in PBS), followed by a 1-hour incubation with biotinylated clone #25 as the detection antibody. Signal development was achieved using HRP-conjugated streptavidin (Thermo Scientific), yielding a lower detection limit of ~3 pM and saturation at 50 nM.
Primary cortical neuron culture and treatment
Primary cortical neurons were isolated from embryonic day-16 WT or PARP1-/- mouse embryos as previously described (5). Cells were seeded in Neurobasal medium supplemented with B-27, 0.5 mM L-glutamine, and 100 U/mL penicillin–streptomycin (Invitrogen, Carlsbad, CA). At DIV 7, cultures were pretreated for 1 hour with one of the following: ABT-888 (veliparib) at 1 µM, AG-014699 (rucaparib) at 1 µM, BMN 673 (talazoparib) at 1 µM. Thereafter, 1 µM oAβ1-42 or 1 µM oAβ1-40 were added, and cells were incubated for the indicated durations before analysis by cell-death assays or biochemical methods.
Synthetic oligomeric oAβ1-42 preparation
Synthetic Aβ1-42 oligomers were generated from lyophilized monomers (rPeptide, Bogart, GA). Briefly, HFIP-treated Aβ1-42 was first dissolved in DMSO, then diluted into PBS to the desired concentration. The solution was incubated at 4 °C for 24 h to allow oligomer formation and subsequently stored at –80 °C. Prior to use, samples were centrifuged at 12,000 × g for 10 min, and the cleared supernatant was collected as the oligomeric Aβ (ADDLs). Oligomerization was confirmed by Western blot analysis (34).
Cell death and viability assessment
Primary cortical neurons were exposed to 1 μM oAβ1–42 (oAβ1–42) for 48 hours. PARP inhibitors, including Talazoparib (BMN 673; LT-673, Catalog No. S7048), AG-14361 (Catalog No. S2178), and Veliparib (ABT-888; NSC 737664, Catalog No. S100), were added 30 minutes prior to oAβ1–42 treatment. Cell death was quantified by co-staining with 7 μM Hoechst 33342 and 2 μM propidium iodide (PI) (Invitrogen), followed by automated image acquisition and analysis on a Zeiss microscope using Axiovision 4.6 software (Carl Zeiss, Dublin, CA). Subsequently, Alamar Blue reagent (Invitrogen) was added, and cell viability was measured fluorometrically (λₑₓ = 570 nm, λₑₘ = 585 nm) as described previously (35).
Tissue Extraction and Immunoblot Analysis
Frozen cortical tissue from dissected brains were homogenized in Tris-buffered saline (TBS) homogenization buffer (20 μl/mg). The sample was centrifuged at 100,000 × g for 1 h at 4° C using Optima TLX Ultracentrifuge (Beckman Coulter). The supernatant was transferred to a prechilled Eppendorf and pellet was resuspended in TBS buffer containing 1% Triton X-100 (20 μl/mg). This time the sample was sonicated and then centrifuged at 100,000 × g for 1h at 4°C using Optima TLX Ultracentrifuge. The supernatant was saved as TBSX soluble. The remaining pellet was finally extracted using 70% formic acid. Following similar rounds of sonication and centrifugation, supernatant was saved as 70% formic acid soluble. This protocol is adapted from (Youmans et al. 2011). For immunoblotting, proteins were resolved by SDS–PAGE using Tris–glycine gels for all targets, except for APP-CTF experiments, which were run on Tris–Tricine gels to improve separation of low-molecular-weight fragments.
Aggregated Aβ extraction
Mouse cortical tissue was lysed using an ice-cold buffer consisting of 10 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM MgCl₂, 0.5 mM DTT, 100 µg/mL cycloheximide, along with protease and RNase inhibitors, and 0.05% sodium deoxycholate. The homogenization was performed with a Dounce homogenizer. The resulting homogenates were incubated at 4 °C for 20 minutes and then cleared through centrifugation at 10,000 rpm for 10 minutes at 4 °C. The supernatants were collected, quantified using a BCA assay, and normalized for total protein content. A sucrose cushion was created by dissolving 2 g of sucrose in 4.7 mL of lysis buffer. For each sample, 900 µL of this cushion was layered beneath 600 µL of the normalized lysate, followed by centrifugation at 70,000 rpm for 2 hours at 4 °C. After ultracentrifugation, the supernatants were carefully removed, and the pellets were resuspended in 60 µL of lysis buffer. The enrichment of aggregates was verified through immunoblotting before proceeding to mass spectrometry.
Amyloid-β ELISA
ELISAs to quantify distinct amyloid species, human Aβ₁–₄₂ (Thermo Fisher Scientific, Cat. #KHB3441),human Aβ₁–₄₀ (Thermo Fisher Scientific, Cat. #KHB3481), and human amyloid precursor protein (APP) (Thermo Fisher Scientific, Cat. #KHB0051), were performed according to the manufacturer’s instructions. Cortical tissue was used for all immunoblot and ELISA analyses. Details of tissue lysate preparation are described in the Tissue Extraction and Immunoblot Analysis section of the Methods. For APP ELISA assays, TBSX-soluble fractions were used.
Immunohistochemistry and immunofluorescence
All mice were perfused with PBS and dissected to preserve half the hemisphere of the brain for immunostaining and other half for western blotting. The half saved for immunostaining was fixed overnight with 4% PFA followed by transfer to 30% sucrose for cryoprotection, where the brains remained until sectioned. Sample brains were sectioned at 50 μm thickness. Brains sections were then processed for immunostaining. By first incubating the sample in antigen retrieval buffer (Thermo catlog-00-4956-58). This was followed by three PBS wash steps. The sections were then permeabilized using 0.3X triton X-100 contained in 10% goat serum. After this, the sections were blocked for an hour. Primary antibody incubation was performed overnight in a cold room. The next day, sections were PBS washed three times before incubating with secondary antibody for an hour at room temperature. After three washes, the samples were mounted using a mounting media containing DAPI. Similar steps were followed for immunofluorescence of primary neurons. For the Thioflavin S staining procedure, each brain section was treated with a 500 µM solution of Thioflavin S (ThS, Sigma-Aldrich, USA) in 50% ethanol for a duration of 7 minutes followed by ethanol washes and were subsequently mounted using mounting media. For Nissl staining, sections were counterstained with Nissl (0.09% thionin). The cell counting was performed using stereo investigator software. Immunofluorescence imaging was performed using confocal microscope- LSM880. Signal intensity and plaque counting was performed using ImageJ software (Kam et al. 2018).
Real-Time Quantitative PCR
For the real-time quantitative PCR (RT-qPCR) procedure, total RNA was isolated utilizing TRIzol, following the manufacturer’s protocol. One microgram of the extracted RNA underwent reverse transcription with the High-Capacity cDNA Reverse Transcription Kit. Gene expression analysis was performed using SYBR Green-based RT-qPCR on an ABI ViiA 7 system (Applied Biosystems, Foster City, CA, USA), with results normalized to GAPDH levels. Forward (F) and reverse (R) primer sequences (5′–3′; human unless indicated) are listed in Table 4.
Behavioral tests
Morris Water Maze
The Morris water maze was performed as published by (Park et al. 2021) with minor modifications. A circular pool (120 cm in diameter and 35 cm in height) was filled with water containing a nontoxic water-soluble white dye. The pool was split into four equal quadrants. A platform (8 cm in diameter) was randomly placed in one of the quadrants such that it does not appear visible (1 cm below the water surface), possibly in the center of that quadrant. Visual cues were attached around the quadrants to act as spatial references. A day before the trials mice were given a 60s swimming training in the absence of a platform. This is followed by a five-day training period wherein the mice swam three time (trials) a day, with an intertrial interval of 30 minutes, to develop memories to allocate the hidden platform, termed as escape latency. During this period, a mice was given 60s to find the platform, if successful within this time frame the test automatically ends, but if they are unsuccessful, they are made to stand on the platform for 10s. On the final day- probe trial, the platform was removed. The mice were again given 60s to swim. The time and distance spent in the target quadrant (previously containing the platform) was recorded. For the entirety of this experiment, ANY-maze software (ANY-maze system, Wood Dale, IL, USA) was used for recording.
Y-maze Spontaneous Alteration
The Y-maze spontaneous alteration was performed as published by (Park et al. 2021) with minor modifications. Mice were given five minutes to freely explore a Y-maze (40 × 8 × 15 cm). Using ANY-maze software the number of arm entries and percent alternations by the mice were recorded. An entry was considered legitimate only when all four limbs of the mice were within the arm.
Open field test
The Open field test was performed as described (Kim et al. 2019). Using Photobeam Activity System/PAS software (SD instruments), a rectangular box (40 cm x 40 cm x 40 cm) was digitally sub divided into 36 (6 x 6) identical sectors (6.6 cm x 6.6 cm), which was further subdivided into peripheral and central sectors. The mouse was placed inside this box in the dark and its movement was monitored via software for 30 minutes (5 minutes each six cycles). Between mouse change, the apparatus was thoroughly cleaned using Vinoba. The time spent in periphery versus the center was collected and graphed as a marker for anxiety.
Quantification and statistical analysis
Quantifications on immunoblots and immunofluorescent data was performed using ImageJ. For PSD95 density analysis, a Matlab script published in a previous paper was repurposed for analysis (39). Each color channel was first converted to binary signal. The Aβ plaque image was used to outline the plaque using binary boundary detection. The code then dilated this boundary by 30 µm and applied the outlines onto the thresholded red channel to compute the area of the PS95 signal as a percentage of total area in each annulus.
All data are represented as mean ± s.e.m. At least 3 independent experiments were performed for in vitro and immunofluorescence experiments. For behavioral experiments, the sample size (n) was about 20 mice. Statistical analysis was performed using GraphPad Prism 9 and CSF associated correlation analysis was performed using IBM SPSS. Differences between 2 means were calculated using an unpaired two-tailed student t test, and among multiple means using ANOVA followed by Tukey’s post hoc test. All p-values from the datasets were consolidated into a single table (Data Set S2), and significant p‑values are also reported directly within the corresponding figure legends for clarity.
Acknowledgements
This work was supported by grants from the NIH NS067525, AG085688, U19AG033655, the Thome Memorial Foundation, and the Alzheimer’s Association Zenith Award. T.M.D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases. This manuscript is the result of funding in whole or in part by the National Institutes of Health (NIH). It is subject to the NIH Public Access Policy. Through acceptance of this federal funding, NIH has been given a right to make this manuscript publicly available in PubMed Central upon the Official Date of Publication, as defined by NIH.
